We are excited to support UC Davis and the Morris Animal Foundation in a novel research. Subvalvular aortic stenosis (SAS) is a common heart defect in dogs which often leads to sudden death. The clinical trial will investigate whether rapamycin can reduce the life-threatening heart remodelling associated with SAS. It is hoped our novel therapy may reduce disease severity and improve outcomes and quality of life for dogs with this devastating disease.